Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Biotech's New Blockbusters -- Oh, Really?
- Biotech's New Blockbusters -- Oh, Really?20 to 30 Blockbusters of Biotech Exist NowInnovation in Pharmacology?Beginning in the 1970, biopharmaceuticals were being researched for conceptual production in those places once called academic institutions. The first biopharmaceutical ever was a synthetic insulin called Humulin made by Genetech in 1982. Later...
- Discussion threads 2008-07-10
- Biotechnology and Pharmaceutical Executives to Convene at SRI International Innovation Forum in Tokyo; SRI Seeks to Collaborate With Japanese Companies and Regional Bioscience Clusters
- MENLO PARK, Calif. -- SRI International, an independent, nonprofit research and development organization, today announced its Tokyo office will host two half-day, invitation-only, biotechnology and pharmaceutical events on October 24 and 25, 2005. Monday, October 24 features technical biotechnology presentations and Tuesday, October 25 features executive-level presentations. The events will...
- Research articles 2005-10-12
- Letters.(Letter to the editor)
- 'Immunity' overstates case Editor: Your Feb. 26 story about the Michigan House of Representatives' attempt to repeal Michigan's tort reforms shed light on an important issue ("State Senate likely to halt drug-liability bill"). However 'Immunity' overstates case ...
- Research articles 2007-03-12
- Ground Zero Pharmaceuticals Announces Milestones in Pharmaceutical and Biotechnology Outsourcing Services.
- IRVINE, California, November 8 /PRNewswire/ -- The climate for pharmaceutical and biotechnology products has changed with increased emphasis on integrated product development, FDA reorganization, and recognition of the need for early markers of s IRVINE, California, November 8 /PRNewswire/ -- ...
- Research articles 2005-11-08
- US Drug Industry Gears Up for Record R&D.(Brief Article)
- Pharmaceutical and biotechnology companies to invest $26.4 billion in 2000. IN 1999, pharmaceutical and biotechnology companies added 40 new treatments--35 drugs and five biologics--to the nation's medicine chest, according to the Pharmaceuti Pharmaceutical and biotechnology companies to invest...
- Research articles 2000-02-07
- GlycoGenesys, Inc. to Present at Bio-Europe 2004 10th International Pharmaceutical and Biotechnology Partnering Conference
- BOSTON -- GlycoGenesys, Inc. (NASDAQ:GLGS), a biotechnology company developing novel drug candidates based on glycobiology, today announced that Frederick E. Pierce, II, Vice President of Business Development will make a corporate presentation at Bio-Europe's 10th International Pharmaceutical Partnering Conference on Tuesday, November 9th, 2004 at 10:15 a.m. Eastern Standard Time....
- Research articles 2004-11-08
- The Funding Stream for Genomics Companies Evaporates.(Statistical Data Included)
- The funding shortfall for biotech companies spills over to genomics companies. With the sharp decline of investor interest in biotech, both public and private funding for genomics and other biotech companies has become very difficult to raise The...
- Research articles 1999-08-16
- Biotechnology Drugs Offer Fertile Ground for API Producers.
- Although they now represent only a small percentage of all pharmaceuticals, biotech-based drugs are projected to show exponential growth. Cynthia Challenger reports. Although sales of biotechnology-based drugs still are a small percentage of Although they now represent...
- Research articles 2001-10-08
- Frost & Sullivan Recognises Speedel's Outstanding Entrepreneurship in Pharmaceutical and Biotechnology Market.
- LONDON, February 19 /PRNewswire/ -- The 2006 Frost & Sullivan Entrepreneurial Company Award is presented to Switzerland-based biotechnology company Speedel for demonstrating superior entrepreneurial ability in the pharmaceutical and biotechno LONDON, February 19 /PRNewswire/ -- The 2006 Frost...
- Research articles 2007-02-19
- MGI PHARMA Announces Change to Presentation Time at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference
- MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that the time of its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference in London, England on Thursday, September 20, 2007 has been changed to 5:00 a.m. ET. Bill Spengler, Executive Vice President and Chief Financial Officer will...
- Research articles 2007-09-19
- Cubist Pharmaceuticals to Present at Upcoming Investor Conferences; Presentations at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference and Bio CEO & Investor Conference
- LEXINGTON, Mass. -- Cubist Pharmaceuticals, Inc. (Nasdaq: CBST) today announced that senior management will present at two February investor conferences. On Wednesday, February 8th, at 8:00 A.M. ET, David McGirr, SVP and CFO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference "Innovation Meets Economics" being...
- Research articles 2006-02-01
- CollaGenex Pharmaceuticals to Present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
- NEWTOWN, Pa. -- CollaGenex Pharmaceuticals, Inc. (NASDAQ:CGPI) today announced that Colin W. Stewart, president and chief executive officer, will present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference. The presentation is scheduled to begin at 1:40 p.m. EST on Thursday, February 8, 2007, at the Grand...
- Research articles 2007-02-01
- Rx for the Bear-Market Blues.
- Byline:Steven Goldberg, Kiplinger Washington Editors With all the major averages in or near bear-market territory and Nasdaq at a two-and-a-half year low, where can an investor seek shelter? Many of the traditional "defensive stocks, ...
- Research articles 2001-04-03
- Altus Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
- CAMBRIDGE, Mass. -- Altus Pharmaceuticals Inc. (NASDAQ: ALTU), a biopharmaceutical company focused on oral and injectable protein therapeutics for patients with gastrointestinal and metabolic disorders, is scheduled to participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York on Tuesday,...
- Research articles 2007-02-01
- AVEO Pharmaceuticals to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
- CAMBRIDGE, Mass. -- AVEO Pharmaceuticals, Inc. today announced that Tuan Ha-Ngoc, president and chief executive officer, is scheduled to present at the Merrill Lynch Nineteenth Annual Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, 2008 at 1:40 p.m. ET at the Grand Hyatt Hotel in New York...
- Research articles 2008-01-30
- Abbott's biotech search; Counting on partnerships, wonder drugs.(Abbott Laboratories)(Statistical Data Included)
- Abbott Laboratories, which for years has hovered near the bottom of the pharmaceutical industry's top-10 international rankings, is now banking on a handful of biotech breakthroughs to leapfrog into the uppermost echelon. A cutting-edge rheumatoid Abbott Laboratories, which for years has hovered near...
- Research articles 2002-03-04
- MGI PHARMA to Present at the Merrill Lynch Global Pharmaceutical Biotechnology and Medical Devices Conference
- MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that Lonnie Moulder, President and Chief Executive Officer of MGI PHARMA, will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Devices Conference in London, England on Thursday, September 20, 2007 at 8:00 a.m. ET. Mr. Moulder will provide an overview...
- Research articles 2007-09-12
- Axcan to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference
- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX: AXP)(NASDAQ: AXCA) today announced that on Tuesday, February 6, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotechnology, and Medical Device Conference to be held in New York....
- Research articles 2007-01-31
- Axcan Pharma to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in London, UK
- Axcan Pharma Inc. ("Axcan" or the "Company") (TSX: AXP)(NASDAQ: AXCA) today announced that on Tuesday, September 18, 2007, President and Chief Executive Officer, Frank Verwiel, M.D., will present an overview of the Company at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference to be held in London, U.K. This...
- Research articles 2007-09-14
- MGI PHARMA to Present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
- MINNEAPOLIS -- MGI PHARMA, INC. (Nasdaq:MOGN) today announced that Lonnie Moulder, President and Chief Executive Officer of MGI PHARMA, will present at the 2007 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference in New York City on Thursday, February 8, 2007 at 10:20 a.m. Eastern Time. Mr. Moulder will...
- Research articles 2007-01-31
- << Previous
- page 1 of 5
- Next >>
Content Types
Refining Tags
- Merrill Lynch & Co. Inc. (19 results)
- medical device (10 results)
- Business Operations (10 results)
- John Maas (8 results)
- Pfizer Inc. (7 results)
- company (7 results)
- Research & Development (6 results)
- FDA (6 results)
- Health Care (5 results)
- Human Resources (5 results)
- Strategy (5 results)
- Management (5 results)
- Federal Government (4 results)
- Outsourcing (4 results)
- Government (4 results)
- Benefits (4 results)
- Vertical Industries (4 results)
- Enterprise Software (4 results)
- Software (4 results)
- Jim Edwards (4 results)
- Biotechnology Company (3 results)
- Sales (3 results)
- Amgen Inc. (3 results)
- Job (3 results)
- Healthcare (3 results)
- Alliance (3 results)
- It Operations (3 results)
- Outsourcing & Subcontracting (3 results)
- David P. Hamilton (3 results)
- Trista Morrison (3 results)
- R&D (3 results)
Premier Vendor Content Whitepapers, webcasts & resources from our Power Center Sponsors
